Cresco Labs Announces Board Director Sidney Dillard’s Resignation
“We are disappointed to see Sidney go, but we wish her the best in her new endeavor. I know she will be the same trusted advisor, independent voice, and driver of evolution in her new role,” said
Ms.
Dillard’s resignation is effective immediately.
About
Facebook:
Instagram:
Twitter:
src="https://cts.businesswire.com/ct/CT?id=bwnewssty=20221024005889r1sid=acqr8distro=nxlang=en" style="width:0;height:0" />
View source version on businesswire.com: https://www.businesswire.com/news/home/20221024005889/en/
Media:
Chief Communications Officer
press@crescolabs.com
Investors:
Senior Vice President, Investor Relations
investors@crescolabs.com
For general
312-929-0993
info@crescolabs.com
Source:


Health Insurance Review and Assessment Service Researchers Describe Findings in Regenerative Medicine (Impact and challenges of enactment for advanced regenerative medicine in South Korea): Biomedical Engineering – Regenerative Medicine
SYSCO CORP FILES (8-K) Disclosing Entry into a Material Definitive Agreement
Advisor News
- Ask the right questions to turn clients into raving fans
- The first 5 years of your career could determine the next 50
- Your client’s $3 million portfolio doesn’t tell you their insurance needs
- How life insurance can provide liquidity for wealthy families
- Retirement providers turn to digital engagement to retain assets
More Advisor NewsAnnuity News
- What lower interest rates mean to annuity payouts
- AM Best downgrades A-Cap insurers amid financial and regulatory troubles
- Lawsuit claims Delaware Life hid billions in insurer-linked investments
- AM Best to Deliver Presentation at 2026 ACLI Annual Conference
- Global Atlantic Announces Launch of ForeLifetime Income, a New Fixed Index Annuity
More Annuity NewsHealth/Employee Benefits News
Life Insurance News